- Home
- PPBT vs BMRA Comparison
PPBT vs BMRA Comparison
Compare PPBT & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPBT
- BMRA
- Stock Information
- Founded
- PPBT 2010
- BMRA 1971
- Country
- PPBT Israel
- BMRA United States
- Employees
- PPBT N/A
- BMRA N/A
- Industry
- PPBT Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PPBT Health Care
- BMRA Health Care
- Exchange
- PPBT Nasdaq
- BMRA Nasdaq
- Market Cap
- PPBT 6.7M
- BMRA 7.4M
- IPO Year
- PPBT N/A
- BMRA N/A
- Fundamental
- Price
- PPBT $3.61
- BMRA $0.29
- Analyst Decision
- PPBT Strong Buy
- BMRA
- Analyst Count
- PPBT 2
- BMRA 0
- Target Price
- PPBT $126.50
- BMRA N/A
- AVG Volume (30 Days)
- PPBT 2.7M
- BMRA 2.3M
- Earning Date
- PPBT 11-15-2024
- BMRA 01-14-2025
- Dividend Yield
- PPBT N/A
- BMRA N/A
- EPS Growth
- PPBT N/A
- BMRA N/A
- EPS
- PPBT N/A
- BMRA N/A
- Revenue
- PPBT N/A
- BMRA $5,509,000.00
- Revenue This Year
- PPBT N/A
- BMRA N/A
- Revenue Next Year
- PPBT N/A
- BMRA N/A
- P/E Ratio
- PPBT N/A
- BMRA N/A
- Revenue Growth
- PPBT N/A
- BMRA 1.74
- 52 Week Low
- PPBT $2.00
- BMRA $0.24
- 52 Week High
- PPBT $20.60
- BMRA $1.42
- Technical
- Relative Strength Index (RSI)
- PPBT 47.73
- BMRA 42.21
- Support Level
- PPBT $3.56
- BMRA $0.27
- Resistance Level
- PPBT $4.22
- BMRA $0.48
- Average True Range (ATR)
- PPBT 1.42
- BMRA 0.05
- MACD
- PPBT -0.07
- BMRA -0.00
- Stochastic Oscillator
- PPBT 3.36
- BMRA 10.00
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.